Neuland to launch commercial peptide facility in Hyderabad as global capacity tightens
The first of four planned modules at the new plant is expected to come online by summer 2026
The first of four planned modules at the new plant is expected to come online by summer 2026
Evogene said ChemPass AI was significantly expanded during 2025 through internal development and collaborations with Google Cloud
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The alliance directly links VivaMed’s computational drug hypotheses with Syngene’s preclinical development capabilities
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
PreemieFort Enteral Solution's approval marks the first time a nutritional product derived from human milk has been recognized as a prescription medicine anywhere in the world
Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY
The pharmaceutical segment led growth, generating Rs. 337 crore in revenue, while the crop protection business contributed Rs. 157 crore
These results were consistent across all clinically relevant patient subgroups regardless of key patient characteristics like age or sex, the cause of stroke or the severity of the stroke
Subscribe To Our Newsletter & Stay Updated